Browse studies
Find your next paid study
2 recruiting studies matching your filters
Phase 3
A Randomized, Double-Blind, Placebo-Controlled, Pivotal Phase 3 Study to Evaluate the Long-Term Efficacy and Safety of Multiple Maintenance Doses of Once Daily Oral Aleniglipron for Chronic Weight Management in Adults With Obesity or Overweight and a Weight-Related Comorbidity
Study GSBR-1290-12 is a Phase 3 pivotal, multicenter, global, randomized, placebo-controlled, double-blind study to investigate the long-term efficacy, safety,…
ObesityOverweightChronic Weight Management
Estimated
~$10 – $8,750
Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure TherapeuticsNCT07654361
Phase 3
A Long-Term Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Multiple Maintenance Doses of Oral Once Daily Aleniglipron for Chronic Weight Management in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
This is randomized, double-blind, placebo-controlled study of the long-term efficacy, safety, and tolerability of multiple doses of aleniglipron in participant…
ObesityOverweightChronic Weight Management+1 more
Estimated
~$10 – $8,750
Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure TherapeuticsNCT07654374